from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2354/-

LFCtreatmentdescriptionclass of inhibitor

-0.056

Amikacinug/mL Amikacintranslation

0.755

Cap5-10ug/mL Capreomycintranslation

0.061

Rox10-50 ug/mL Roxithromycintranslation

-0.465

SM2-5 ug/mL Streptomycintranslation

0.425

Tet5-10 ug/mL Tetracyclinetranslation

-1.218

Rif0.2-5ug/mL Rifampicintranscription

-0.792

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.281

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.229

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.452

CPZ10-50 ug/mL Chlorpromazinerespiration

0.053

Clofazimine10-13 ug/mL Clofaziminerespiration

0.364

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.570

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.161

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.635

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.452

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.241

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.331

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.612

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.390

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.406

KCN5-20 ug/mL Potassium cyaniderespiration

1.291

NaN30.2-2 mM Sodium aziderespiration

0.207

Nigericin50 uM Nigericinrespiration

0.278

TRC10-150 ug/mL Triclosanrespiration

-1.168

TRZ10-25 ug/mL Thioridazinerespiration

1.996

Valinomycin0.5-10 uM Valinomycinrespiration

-0.176

ZnSO42 mM ZnSO4respiration

-0.106

menadione6-10 ug/mL Menadionerespiration

-0.702

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.339

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.767

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.543

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.624

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

-0.070

Cephalexin20-100 ug/mL CephalexincellWall

0.039

Cerulenin0.32-5 ug/mL CerulenincellWall

0.987

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.053

EMB10-20 ug/mL EthambutolcellWall

0.008

Eta12-40 ug/mL EthionamidecellWall

0.235

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.401

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.246

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.803

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.444

BZA0.12 mg/mL BenzamidearomaticAmides

0.236

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.860

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.219

H2O24 mM hydrogen peroxideDNAdamaging

-0.045

Levo10 ug/mL LevofloxacinDNAdamaging

0.034

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.969

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.010

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.071

UVUV-irradiationDNAdamaging

-2.325

ARP41-4 ug/mL Antitubercular compound ARP4?

0.440

Antimycin12.5-50 ug/mL Antimycin A?

0.541

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.121

PA_110-50 ug/mL Antitubercular compound PA-1?

0.896

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.117

PA8240.2-2 ug/mL PA-824?

0.110

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.230

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.360

Verapamil50 uM Verapamil?

0.428

mercaptoethanol2 mM 2-Mercaptoethanol?

0.048

methoxatin10-20 ug/mL Methoxatin?